Navigation Links
GenVault Corporation to Present at the 2009 BIOCOM Investor Conference
Date:10/24/2009

CARLSBAD, Calif., Oct. 23 /PRNewswire/ -- GenVault Corporation, the leader in ambient temperature biosample management for genomic discovery, medicine and identification, today announced that David Wellis, Ph.D., GenVault's President and CEO, will be presenting at the BIOCOM Investor Conference taking place on October 26th and 27th in La Jolla, CA.

During the presentation, Dr. Wellis will provide an overview of the company together with recent customer, technical and strategic developments that have enabled GenVault to target the broader life sciences transport and storage markets. The major advantages of GenVault's technologies are the reduction of cost, waste and complexity associated with traditional biosample management in the academic and commercial sectors of the life sciences marketplace.

The following are specific details of GenVault's presentation at the conference:

BIOCOM Investor Conference

Date: Monday, October 26th, 2009

Time: 4:00pm (Track 2)

Location: Hyatt Regency La Jolla

Room: Aventine Ballroom, Room B

About GenVault

GenVault is the global leader in providing risk free biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable, reliable and environmentally friendly alternative to traditional freezers and DNA purification systems, the company's dry-state platform enables the extraction, preservation, recovery, and distribution of biosamples at ambient temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlates to the Dynamic Archive, GenVault is continuously developing and refining best practices biosample management and preservation. For more information visit GenVault at www.genvault.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Bret Dash

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87941

    BUSINESS CONTACT:
    Bret Dash
    Director of Marketing
    (760) 717-3774
    bdash@genvault.com

SOURCE GenVault Corporation


'/>"/>
SOURCE GenVault Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. Harris Corporation Adds Broadband Satellite Data Mode to JTRS-Approved Falcon III(R) AN/PRC-117G Multiband Manpack Radio
2. M2SYS Biometric Software Solution Selected By GHG Corporation
3. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
4. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
5. $29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation
6. delSECUR CORPORATION Announces Appointment of the Companys President & CEO
7. CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
8. Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results
9. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
10. Carbon Disclosure Project: Worlds largest corporations seek clarity on climate change regulation
11. L-1 Identity Solutions Completes Acquisition of the ID Systems Business from Digimarc Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology: